Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

Sometimes the most powerful tools are hiding in plain sight #shorts

14 Jan 2026 · 0 min

Watch on YouTube

0:27

In this concise YouTube short, the speaker explains that when damage‑associated molecular pattern (DAMP) markers are elevated, low‑dose (microdose) naltrexone can be used off‑label as an adjunct therapy. Citing published data, the speaker argues that micro‑dosed naltrexone helps shift a harmful inflammatory response toward a beneficial immune‑modulatory state by targeting and calming immune cells, thereby supporting overall care.

So when the DAMP markers are present and you can test for them and they're in excess, then low dose naltrexone comes in to help. And evidence in the published data shows that naltrexone in the right microdoses becomes an excellent choice as an off label adjuvant alongside your other care to shift from a bad inflammatory response to a good immune modulatory response, all based on targeting and calm the immune cells to get back on track.